Vor Biopharma Inc.
VOR | NASDAQ
$23.12
+$1.23 (+5.62%)
Sep 22, 2026, 2:36 PM ET · Market open
Market Data
Market Cap $1.19B
Enterprise Value $722.88M
Beta 1.72
Average Volume 1.04M
Shares Outstanding (Diluted) 54.3M
Shares Change YoY 766.99%
Institutional Ownership 74.48%
Exchange NASDAQ
ISIN US9290332074
Price Performance
Price Change 1M -5.9%
Price Change 3M 47.4%
Price Change 6M 69.2%
Price Change YTD 88.1%
Price Change 1Y -21.6%
Price Change 3Y -49.3%
Price Change 5Y -91.9%
1M CAGR (ann.) -7.5%
1Y CAGR (ann.) -28.0%
5Y CAGR (ann.) -41.7%
All-Time CAGR -46.6%
Valuation
PE Ratio -0.04
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS 118.60
PB Ratio -5.92
P/FCF Ratio -8.41
P/Adj. FCF Ratio -6.73
P/OCF Ratio -8.45
EV/Sales N/A
EV/EBIT 1.12
EV/EBITDA 1.12
EV/FCF -5.12
Earnings Yield -2689.9%
FCF Yield -11.9%
Adj. FCF Yield -14.9%
Financial Health
Net Cash $466.13M
Total Debt $2.88M
Cash & Short-Term Investments $466.13M
Total Assets $481.05M
Current Ratio 19.15
Quick Ratio 19.15
Debt / Equity Ratio -0.01
Debt / EBITDA 0.00
Debt / FCF -0.02
OCF / Debt -48.79
Interest Coverage 0.00
Altman Z-Score 2.40
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -25.0%
Returns
Return on Assets 130.5%
Return on Equity -91.6%
Return on Invested Capital -32.2%
Return on Capital Employed -32.2%
Return on Tangible Assets 130.5%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -92.6%
EPS CAGR 5Y -67.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -15.1%
FCF CAGR 5Y -11.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y 33.1%
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.81
EPS Growth Est (next Q) -99.3%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $29
Price Target Upside 32.5%
Cash Flow
Operating Cash Flow $-140.38M
Free Cash Flow $-141.11M
Adj. Free Cash Flow $-176.36M
FCF Per Share -$2.60
OCF Per Share -$2.59
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-28K
Operating Income $-147.08M
EBITDA $642.79M
Net Income $627.78M
EPS (Diluted) -$588.82
Revenue / Employee N/A
Profit / Employee $8.26M
Employees 76
Add to Watchlist
Select watchlists to add or remove VOR